The exception to this observation was a marked reduction in overall percentage of CD8-positive cells, which fell from 17.8% in the minimal chronic interstitial inflammation ROI to 5.7% in the areas with diffuse inflammatory damage (figure 6B). This evidence concerns the gene CD8A and inflammatory response.